Scienture Holdings (SCNX) said Thursday that Suren Ajjarapu has stepped down as chief executive and chairman, with Dr. Shankar Hariharan and Dr. Narasimhan Mani taking over as co-CEOs.
Hariharan, named executive chairman, led Scienture before its 2024 merger with the current company, and Mani was appointed president and co-CEO after previously leading Scienture LLC, the company said.
Both executives were already leading the company's pharmaceutical unit and will continue in those positions, Scienture said.
Scienture also said Ajjarapu will remain an advisor to the board after overseeing the company's merger and exit from its healthcare IT platform.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.